✦ LIBER ✦

Magnetic-induction hyperthermia. Results of a 5-year multi-institutional national cooperative trial in advanced cancer patients

✍ Scribed by F. Kristian Storm; Harvey W. Baker; Edward F. Scanlon; Henry P. Plenk; Paul M. Meadows; Stephen C. Cohen; Carl E. Olson; John W. Thomson; Janardan D. Khandekar; Denise Roe; Anne Nizze; Donald L. Morton

Book ID: 102670903
Publisher: John Wiley and Sons
Year: 1985
Tongue: English
Weight: 999 KB
Volume: 55
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19850601)55:11<2677::aid-cncr2820551124>3.0.co;2-o

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vorinostat in advanced prostate cancer p

Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862) : Trial results and interleukin-6 analysis: A study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago Phase 2 Consortium

✍ Deborah Bradley; Dana Rathkopf; Rodney Dunn; Walter M. Stadler; Glenn Liu; David 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views

726 - Long-term weekly treatment of adva

726 - Long-term weekly treatment of advanced colorectal cancer (CRC) with fluorouracil (5-FU) and leucovorin (LV): 5 year-results of a multicentric phase II trial of 5-FU pharmacokinetic monitoring in 152 patients

✍ B. Lamezec; C. Alleaume; E. Gamelin; M.J. Goudier; P.E. Cailleux; E. Danquechin- 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 217 KB

Alemtuzumab in Combination With Methylpr

Alemtuzumab in Combination With Methylprednisolone Is a Highly Effective Induction Regimen for Patients With Chronic Lymphocytic Leukemia and Deletion of TP53: Final Results of the National Cancer Research Institute CLL206 Trial

✍ Pettitt, A. R.; Jackson, R.; Carruthers, S.; Dodd, J.; Dodd, S.; Oates, M.; John 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 246 KB

Postoperative dose-dense sequential vers

Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial

✍ Helen Gogas; Urania Dafni; Maria Karina; Christos Papadimitriou; Anna Batistatou 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 486 KB

93 POSTER Phase I study of daily oral AZ

93 POSTER Phase I study of daily oral AZD2171, an inhibitor of the vascular endothelial growth factor receptors (VEGFR), in combination with oxaliplatin and Infusional 5-Fu (mFOLFOX6) in patients with advanced colorectal cancer (CRC): a study of the National Cancer Institute of Canada Clinical Trials Group

✍ E. Chen; D. Jonker; M. Maclean; J. Wells; S. Mathews; J. Robertson; L. Seymour 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 57 KB

5.44 Consolidation Therapy with Subcutan

5.44 Consolidation Therapy with Subcutaneous Alemtuzumab after Induction Treatment with Oral Fludarabine and Cyclophosphamide in Previously Untreated Patients Aged 65-70 years with Advanced Stage CLL: Final Results of a Phase II Study from the French Cooperative Group on Chronic Lymphocytic Leukemia and Waldenstrom Macroglobulinemia (FCG-CLL/WM)

✍ Alain Delmer; Olivier Tournilhac; Stéphane Leprêtre; Bruno Cazin; Pierre Feugier 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 113 KB